Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02221934 · ClinicalTrials.gov registry record · NA
Electrical Nerve Block for Amputation Pain
A NA study of Phantom Limb Pain and Residual Limb Pain, sponsored by Neuros Medical.
- Active
- Registry status
- NA
- Development phase
- 607
- Enrollment target
- 20
- Study locations
NCT02221934: Active NA study of Phantom Limb Pain and Residual Limb Pain, sponsored by Neuros Medical.
NCT02221934 is a NA study of Phantom Limb Pain and Residual Limb Pain that is active but no longer recruiting, run by Neuros Medical. The registered enrollment target is 607 participants, above the 72-participant average among 12 other Phantom Limb Pain trials with a reported enrollment target (743% higher). The trial reports 20 study locations across 15 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02221934, a NA study of Phantom Limb Pain and Residual Limb Pain, is active but no longer recruiting, sponsored by Neuros Medical.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 607 participants
- Enrollment target
- 20
- Study locations
Study Summary
The purpose of the clinical trial is to learn whether electrical nerve block via the Altius System is a safe and effective treatment for patients with post-amputation pain.
Primary Outcome
Demonstration of 50% reduction in a Numerical Rating Scale (NRS; 0-10 Scale; with 10 being the highest pain imaginable) pain score from pre-treatment to post-treatment for more than 50% of all pain episodes. Study success will be determined by a superiority test on the difference between responder rates in the Test group (those receiving the treatment) and Control group (those who do not receive treatment).
Conditions Studied
Interventions
- DEVICE Altius
Study Locations (20)
Georgia
- Emory University / Grady Hospital - Atlanta
- Legacy Brain & Spine LLC - Atlanta
- Drug Studies America - Marietta
Ohio
- Cleveland Clinic Pain Management - Cleveland
- Meta Medical Research Institute - Dayton
- Kettering Medical Center - Springboro
Tennessee
- Cardiovascular Surgery Clinic - Memphis
- The Surgical Clinic - Nashville
Arizona
- Arizona Pain Institute - Scottsdale
Arkansas
- University of Arkansas for Medical Sciences (UAMS) - Little Rock
Colorado
- HCA Healthcare Research Institute / St. Luke's Presbyterian - Denver
Florida
- Nona Medical Arts - Orlando
Illinois
- University of Illinois Chicago - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 607 participants |
| Start Date | 2014-10-09 |
| Est. Completion | 2025-09-01 |
| Phase | NA |
What the registry record for NCT02221934 still lists
NCT02221934 is an interventional study that assigns participants to a tested intervention. The registered 607 participants enrollment target is mid-sized for trials with a published cap, above the 72-participant average among 12 other Phantom Limb Pain trials with a reported enrollment target (743% higher).
The record links to 4 conditions, with Phantom Limb Pain appearing as the primary indexed condition, and to 1 intervention - of which Altius is the first listed.
NCT02221934 names 20 study sites across 15 states, led by Georgia, Ohio, Tennessee.
Frequently Asked Questions
What is clinical trial NCT02221934 about?
NCT02221934 is a clinical study titled "Electrical Nerve Block for Amputation Pain". The purpose of the clinical trial is to learn whether electrical nerve block via the Altius System is a safe and effective treatment for patients with post-amputation pain.
What is the current status of trial NCT02221934?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 607 participants. The study started on 2014-10-09. Estimated completion is 2025-09-01.
What conditions does trial NCT02221934 study?
This clinical trial studies the following conditions: Phantom Limb Pain, Residual Limb Pain, Post-Amputation Pain, Stump Pain.
What interventions are being tested in trial NCT02221934?
The interventions under investigation include: Altius (DEVICE).
Who is sponsoring clinical trial NCT02221934?
This trial is sponsored by Neuros Medical, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02221934 being conducted?
This trial has 20 study locations across Arizona, Arkansas, Colorado, Florida, Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Phantom Limb Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02221934's enrollment target sits among peer trials
607 1st of 12 higher than 12 of 12 other Phantom Limb Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phantom Limb Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Surgical Treatments for Postamputation Pain
RECRUITING · NA
-
Home-based Rehabilitation Intervention for Phantom Limb Pain in Veterans With Lower Limb Amputations
RECRUITING · NA
-
Pragmatic Trial of Remote tDCS and Somatosensory Training for Phantom Limb Pain With Machine Learning to Predict Treatment Response
RECRUITING · NA
-
Optimizing Rehabilitation for Phantom Limb Pain Using Mirror Therapy and Transcranial Direct Current Stimulation (tDCS)
ACTIVE NOT RECRUITING · NA
-
Closed-loop Deep Brain Stimulation to Treat Refractory Neuropathic Pain
ACTIVE NOT RECRUITING · NA
-
VR to Evaluate Phantom Limb Pain
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02064673 · 608 participants · Phase 3
Adjuvant Curcumin to Assess Recurrence Free Survival in Patients Who Have Had a Radical Prostatectomy
- NCT06091202 · 608 participants · Phase 3
Tele-Collaborative Outreach to Rural Patients With Chronic Pain
- NCT06098144 · 608 participants · Phase 4
Smoking Cessation Program in the Construction Sector
- NCT02342444 · 606 participants · Phase 4
Lovenox 30 mg Twice Daily (BID) Versus 40 mg Once Daily (QD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI